Keros Therapeutics, Inc.
Keros Therapeutics, Inc. scores highest on Torque (62) and lowest on Earnings (14). Its PosiPenta is 40.42 out of 100, around the middle of similar companies.
On the Penta Grid this week, Keros Therapeutics, Inc. is Grid #529 of 837 in the Healthcare sector in United States, and Grid #2,843 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | 40.42 | 42 | 14 | 39 | 62 | 45 |
| TriSalus Life Sciences, Inc. | 35.27 | 1 | 57 | 47 | 4 | 66 |
| Spok Holdings, Inc. | 64.44 | 65 | 68 | 52 | 72 | 66 |
| SIGA Technologies, Inc. | 58.32 | 34 | 87 | 32 | 78 | 60 |
| Greenwich LifeSciences, Inc. | 38.62 | 1 | 47 | 46 | 45 | 54 |
| Electromed, Inc. | 59.14 | 45 | 48 | 52 | 86 | 64 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.31 |
| P/B ratio | 0.81 |
EEarnings
| Trailing EPS | ₹-304.98 |
| Forward EPS | ₹-626.63 |
NNitro
| Price | 1009.66 |
| 52-week high | 2135.82 |
| 52-week low | 917.79 |
| Fall from 52-week high | 52.7% |
TTorque
| Return on equity (ROE) | -17.16% |
| Debt-to-equity | 0.06 |
AAnchor
| Beta (price swings) | 1.12 |
| Market cap | ₹2,001 Cr |
| Insider holding | 3.96% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Keros Therapeutics, Inc.'s PosiPenta score?
Keros Therapeutics, Inc.'s PosiPenta is 40.42 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Keros Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Keros Therapeutics, Inc. is Grid #529 of 837 in the Healthcare sector in United States, and Grid #2,843 of 4,000 in United States.
Which PosiPenta pillar is strongest for Keros Therapeutics, Inc.?
Torque (durability), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Keros Therapeutics, Inc.?
Earnings (growth), with a score of 14 out of 100: much weaker than most similar companies.
Has Keros Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.84 points, from 37.58 to 40.42.
PositoAI is for research and education only and is not investment advice.